Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

COVID-19 Map Tracker | COVID-19 News Features


feed-image RSS

Press Releases

Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.


SAN DIEGO, Oct. 23, 2021 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Katapult Holdings, Inc. f/k/a FinServ Acquisition Corp. (NASDAQ: KPLT; KPLTW) securities between December 18, 2020 and August 10, 2021, both dates inclusive (the “Class Period”) have until this upcoming Tuesday, October 26, 2021 to seek appointment as lead plaintiff in the Katapult class action lawsuit. The Katapult class action lawsuit – McIntosh v. Katapult Holdings, Inc. f/k/a FinServ Acquisition Corp., No. 21-cv-07251 – charges Katapult and certain of its top executives with violations of the Securities Exchange Act of 1934. The Katapult class action lawsuit was commenced on August 27, 2021 and is pending in the Southern District of New York.


If you wish to serve as lead plaintiff of the Katapult class action lawsuit, please provide your information by clicking here. You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it.. Lead plaintiff motions for the Katapult class action lawsuit must be filed with the court no later than October 26, 2021.

CASE ALLEGATIONS: FinServ was a blank check company, or special purpose acquisition company (“SPAC”), formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. On December 18, 2020, FinServ announced that it had entered into a definitive merger agreement with legacy Katapult.

The Katapult class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) Katapult was experiencing declining e-commerce retail sales and consumer spending; (ii) despite Katapult’s assertions that it delivers a clear and compelling value proposition to both consumers and merchants, transforming the way nonprime consumers shop for essential goods and enabling merchant access to this underserved segment, Katapult lacked visibility into its consumers’ future buying behavior; and (iii) as a result, defendants’ positive statements about Katapult’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

On August 10, 2021, Katapult issued a press release announcing disappointing financial results for the second quarter of 2021 including a net loss of $8.1 million, compared to $5.1 million in net income for the second quarter of 2020. Katapult further disclosed that it “observed meaningful [negative] changes in both e-commerce retail sales forecasts and consumer spending behavior” and retracted its full year 2021 guidance, claiming it could not “accurately predict our consumer’s buying behaviors for the remainder of the year.” On this news, Katapult’s share price fell more than 56%, damaging investors.

Robbins Geller Rudman & Dowd LLP has launched a dedicated SPAC Task Force to protect investors in blank check companies and seek redress for corporate malfeasance. Comprised of experienced litigators, investigators, and forensic accountants, the SPAC Task Force is dedicated to rooting out and prosecuting fraud on behalf of injured SPAC investors. The rise in blank check financing poses unique risks to investors. Robbins Geller Rudman & Dowd LLP’s SPAC Task Force represents the vanguard of ensuring integrity, honesty, and justice in this rapidly developing investment arena.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Katapult securities during the Class Period to seek appointment as lead plaintiff in the Katapult class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Katapult class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Katapult class action lawsuit. An investor’s ability to share in any potential future recovery of the Katapult class action lawsuit is not dependent upon serving as lead plaintiff.

ABOUT ROBBINS GELLER RUDMAN & DOWD LLP: With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman & Dowd LLP is the largest U.S. law firm representing investors in securities class actions. Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering $1.6 billion for investors last year, more than double the amount recovered by any other securities plaintiffs’ firm. Please visit http://www.rgrdlaw.com for more information.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
This email address is being protected from spambots. You need JavaScript enabled to view it.


SAN DIEGO, Oct. 23, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA) against certain of its officers and directors. 

Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of Athira from September 18, 2020 and June 17, 2021 (the "Class Period").

The Athira Pharma class-action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) the research conducted by Athira Pharma's President and Chief Executive Officer, defendant Leen Kawas, which formed the foundation for Athira Pharma's product candidates and intellectual property, was tainted by Kawas's scientific misconduct, including the manipulation of key data; and (ii) as a result, defendants' positive statements about Athira Pharma's business, operations, and prospects were materially misleading and omitted material facts necessary to make the statements made not misleading.

If you are a current shareholder of Athira, holding shares before November 2020, you may have standing to hold Athira harmless from the alleged harm caused by the officers and directors of the Company by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing. Click here to join this action

If you are interested in learning more about the investigation, please contact lead analyst Jim Baker (This email address is being protected from spambots. You need JavaScript enabled to view it.) at 619-814-4471. If emailing, please include a phone number.

Additionally, if you are a current, long-term shareholder of Athira, holding shares before November 2020, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

[Click here to join this action]


NEW YORK, Oct. 23, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021, inclusive (the “Class Period”), of the important November 1, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Spectrum Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Spectrum Pharmaceuticals class action, go to http://www.rosenlegal.com/cases-register-2153.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 1, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the manufacturing facility of ROLONTIS (eflapegrastim), a long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia, maintained deficient controls and/or procedures; (2) the foregoing deficiencies decreased the likelihood that the U.S. Food and Drug Administration (“FDA”) would approve the ROLONTIS Biologics License Application (the “ROLONTIS BLA”) in its current form; (3) Spectrum Pharmaceuticals had therefore materially overstated the ROLONTIS BLA’s approval prospects; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Spectrum Pharmaceuticals class action, go to http://www.rosenlegal.com/cases-register-2153.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        www.rosenlegal.com




NEW YORK, Oct. 23, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares (“ADSs”) of Waterdrop Inc. (NYSE: WDH) pursuant and/or traceable to the Company’s initial public offering conducted in May 2021 (the “IPO”), of the important November 15, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Waterdrop ADSs pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Waterdrop class action, go to http://www.rosenlegal.com/cases-register-2158.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 15, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO’s registration statement featured false and/or misleading statements and/or failed to disclose that: (1) Waterdrop had achieved a substantial portion of its historical revenue growth through illicit means that ran afoul of Chinese rules and regulations governing the insurance industry; (2) Waterdrop had been ordered by the Chinese government to shut down its mutual aid platform because of its failure to comply with Chinese law; (3) Waterdrop was under investigation by regulatory authorities for continued violations of Chinese law; (4) as a result of the foregoing, there existed a material undisclosed risk and substantial likelihood that Waterdrop would face severe adverse actions by regulatory authorities following the IPO; (5) Waterdrop’s operating losses had increased more than four-fold in the first quarter of 2021 as a result of the cessation of its mutual aid business and rapidly growing customer acquisition costs; and (6) as a result of the foregoing, the IPO registration statement’s representations regarding Waterdrop’s historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of the Company in the lead up to the IPO, were materially false and misleading, and lacked a factual basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Waterdrop class action, go to http://www.rosenlegal.com/cases-register-2158.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        This email address is being protected from spambots. You need JavaScript enabled to view it.
        www.rosenlegal.com


NEW YORK, Oct. 23, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TriState Capital Holdings, Inc. (NASDAQ: TSC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Raymond James Financial, Inc. Under the terms of the agreement, TriState Capital common stockholders will receive $6.00 in cash and 0.25 Raymond James shares for each share of TriState Capital common stock they own. If you are a TriState Capital shareholder, click here to learn more about your rights and options.

ADTRAN, Inc. (NASDAQ: ADTN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with ADVA. Following completion of the transaction, ADTRAN shareholders are expected to own approximately 54% of the combined company. If you are an ADTRAN shareholder, click here to learn more about your rights and options.

Great Western Bancorp, Inc. (NYSE: GWB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Interstate BancSystem, Inc. Under the terms of the agreement, Great Western shareholders will receive 0.8425 shares of First Interstate Class A common stock for each Great Western share they own. Following completion of the transaction, Great Western shareholders will collectively own 43% of the combined company. If you are a Great Western shareholder, click here to learn more about your rights and options.

Teekay LNG Partners L.P. (NYSE: TGP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Stonepeak for $17.00 in cash per common unit or common unit equivalent. If you are a Teekay LNG shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it..

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.  
https://www.halpersadeh.com




SAN DIEGO, Oct. 23, 2021 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Waterdrop, Inc. ("Waterdrop” or the "Company") (NYSE: WDH). The class action is on behalf of shareholders who purchased Waterdrop common stock shares pursuant and traceable to the Company's initial public offering conducted in May 2021 (the "IPO"). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than November 15, 2021.

[click here to join this action]

According to the complaint, Waterdrop's IPO Registration Statement contained false and misleading statements and/or failed to disclose that: (1) Waterdrop had achieved a substantial portion of its historical revenue growth through illicit means that ran afoul of Chinese rules and regulations governing the insurance industry; (2) Waterdrop had been ordered by the Chinese government to shut down its mutual aid platform because of its failure to comply with Chinese law; (3) Waterdrop was under investigation by regulatory authorities for continued violations of Chinese law; (4) as a result of the foregoing, there existed a material undisclosed risk and substantial likelihood that Waterdrop would face severe adverse actions by regulatory authorities following the IPO; (5) Waterdrop's operating losses had increased more than four-fold in the first quarter of 2021 as a result of the cessation of its mutual aid business and rapidly growing customer acquisition costs; and (6) as a result of the foregoing, the IPO registration statement's representations regarding Waterdrop's historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of the Company in the lead up to the IPO, were materially false and misleading, and lacked a factual basis. When the actual details entered the market, the lawsuit claims that investors suffered damages.

A lead plaintiff will act on behalf of all other class members in directing the Waterdrop class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor's ability to share any potential future recovery of the Waterdrop class action lawsuit is not dependent upon serving as lead plaintiff.

If you suffered a substantial loss and are interested in learning more about being a lead plaintiff, please contact Jim Baker (This email address is being protected from spambots. You need JavaScript enabled to view it.) by email or phone at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
This email address is being protected from spambots. You need JavaScript enabled to view it.
[click here to join this action]